← FDA Drug Approvals (Drugs@FDA)

CABERGOLINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA INTL · Approved 2005-12-29

Drug application

FDA Application #

ANDA076310

Application type

Abbreviated New Drug Application (Generic)

Brand name

CABERGOLINE

Generic name

CABERGOLINE

Active ingredients

CABERGOLINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

STRIDES PHARMA INTL

Manufacturer

SOLA Pharmaceuticals, LLC

First approval

2005-12-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown